Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canadian Pathology Quality Assurance is a Canadian not-for-profit organization focused on improving the quality of biomarker testing in diagnostic medical laboratories. It provides external quality assurance and proficiency testing programs spanning immunohistochemistry and molecular pathology, including end-to-end molecular assessments that evaluate analytical accuracy, turnaround time, report interpretation, and reporting clarity. The organization distributes clinically validated samples and supports laboratories with biomarker optimization and validation assistance. CPQA serves laboratories in Canada and internationally and is positioned as a healthcare quality infrastructure organization rather than a therapeutic drug developer. Its work supports precision oncology by helping ensure reliable pathology and molecular test results used to guide treatment decisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Pathology Quality Assurance.